| pubmed-article:15860501 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15860501 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:15860501 | lifeskim:mentions | umls-concept:C1268855 | lld:lifeskim |
| pubmed-article:15860501 | lifeskim:mentions | umls-concept:C0242813 | lld:lifeskim |
| pubmed-article:15860501 | lifeskim:mentions | umls-concept:C0083220 | lld:lifeskim |
| pubmed-article:15860501 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:15860501 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:15860501 | lifeskim:mentions | umls-concept:C1511572 | lld:lifeskim |
| pubmed-article:15860501 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15860501 | pubmed:dateCreated | 2005-5-19 | lld:pubmed |
| pubmed-article:15860501 | pubmed:abstractText | The specific role of LH in folliculogenesis and oocyte maturation is unclear. GnRH antagonists, when administered in the late follicular phase, induce a sharp decrease in serum LH which may be detrimental for IVF outcome. This study was performed to evaluate whether the replacement of GnRH agonist (triptorelin) by a GnRH antagonist (ganirelix; NV Organon) in oocyte donation cycles has any impact on pregnancy and implantation rates. | lld:pubmed |
| pubmed-article:15860501 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15860501 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15860501 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15860501 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15860501 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15860501 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15860501 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15860501 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15860501 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15860501 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15860501 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15860501 | pubmed:issn | 0268-1161 | lld:pubmed |
| pubmed-article:15860501 | pubmed:author | pubmed-author:SchoysmanRR | lld:pubmed |
| pubmed-article:15860501 | pubmed:author | pubmed-author:PrapasNN | lld:pubmed |
| pubmed-article:15860501 | pubmed:author | pubmed-author:PrapaSS | lld:pubmed |
| pubmed-article:15860501 | pubmed:author | pubmed-author:Vanderzwalmen... | lld:pubmed |
| pubmed-article:15860501 | pubmed:author | pubmed-author:MakedosGG | lld:pubmed |
| pubmed-article:15860501 | pubmed:author | pubmed-author:PrapasYY | lld:pubmed |
| pubmed-article:15860501 | pubmed:author | pubmed-author:PanagiotidisY... | lld:pubmed |
| pubmed-article:15860501 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15860501 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:15860501 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15860501 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15860501 | pubmed:pagination | 1516-20 | lld:pubmed |
| pubmed-article:15860501 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:meshHeading | pubmed-meshheading:15860501... | lld:pubmed |
| pubmed-article:15860501 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15860501 | pubmed:articleTitle | GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study. | lld:pubmed |
| pubmed-article:15860501 | pubmed:affiliation | 4th Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece. | lld:pubmed |
| pubmed-article:15860501 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15860501 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15860501 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15860501 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15860501 | lld:pubmed |
